Chen, M., Ji, Y., Chen, L., Pang, Q., Jiang, O., Ge, H., Cheng, Y., Zhou, R., Meng, X., Min, X., Wang, H., Yang, H., Xie, Y., Zheng, A., Li, J., Xia, B., Hu, D., Zhang, X., Chen, Y., Li, W. (2025). R-ALPS: A randomized, double-blind, placebo-controlled, multicenter phase III clinical trial of TQB2450 with or without anlotinib as maintenance treatment in patients with locally advanced and unresectable (stage III) NSCLC without progression following concurrent or sequential chemoradiotherapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.17_suppl.lba8004